Michael Ehrhardt

887 total citations
20 papers, 702 citations indexed

About

Michael Ehrhardt is a scholar working on Genetics, Hematology and Genetics. According to data from OpenAlex, Michael Ehrhardt has authored 20 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Hematology and 5 papers in Genetics. Recurrent topics in Michael Ehrhardt's work include Glioma Diagnosis and Treatment (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Virus-based gene therapy research (2 papers). Michael Ehrhardt is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Virus-based gene therapy research (2 papers). Michael Ehrhardt collaborates with scholars based in United States, Germany and Japan. Michael Ehrhardt's co-authors include Bruce R. Blazar, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Christopher J. Lees, Norbert Graf, Patricia A. Taylor, Lien Vandenberk, Patrizia Agostinis, Abhishek D. Garg and Steven De Vleeschouwer and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Michael Ehrhardt

19 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ehrhardt United States 13 295 224 211 175 166 20 702
Randall Armstrong United States 18 560 1.9× 190 0.8× 349 1.7× 445 2.5× 58 0.3× 37 1.4k
Amy Cuthbert United States 7 318 1.1× 71 0.3× 185 0.9× 109 0.6× 149 0.9× 10 613
Sabine Hahn Germany 8 320 1.1× 152 0.7× 375 1.8× 119 0.7× 43 0.3× 9 770
William Siders United States 15 472 1.6× 44 0.2× 274 1.3× 266 1.5× 176 1.1× 26 875
J. E. Landegent Netherlands 12 297 1.0× 305 1.4× 224 1.1× 170 1.0× 183 1.1× 23 709
Nancy Pech United States 15 398 1.3× 143 0.6× 299 1.4× 217 1.2× 278 1.7× 26 764
Sohel Talib United States 14 236 0.8× 79 0.4× 192 0.9× 131 0.7× 79 0.5× 24 605
Martina Minnich Austria 13 1.1k 3.9× 166 0.7× 505 2.4× 210 1.2× 129 0.8× 15 1.7k
Pierre Rollini Switzerland 16 569 1.9× 69 0.3× 285 1.4× 63 0.4× 223 1.3× 22 960

Countries citing papers authored by Michael Ehrhardt

Since Specialization
Citations

This map shows the geographic impact of Michael Ehrhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ehrhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ehrhardt more than expected).

Fields of papers citing papers by Michael Ehrhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ehrhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ehrhardt. The network helps show where Michael Ehrhardt may publish in the future.

Co-authorship network of co-authors of Michael Ehrhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ehrhardt. A scholar is included among the top collaborators of Michael Ehrhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ehrhardt. Michael Ehrhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Panoskaltsis‐Mortari, Angela, Michael Ehrhardt, George L. Wilcox, et al.. (2021). Expression of and correlational patterns among neuroinflammatory, neuropeptide, and neuroendocrine molecules from cerebrospinal fluid in cerebral palsy. BMC Neurology. 21(1). 384–384. 3 indexed citations
3.
Meyer, Carolyn, Michael Ehrhardt, Rachel Blue, et al.. (2021). Engineering Functional Vasculature in Decellularized Lungs Depends on Comprehensive Endothelial Cell Tropism. Frontiers in Bioengineering and Biotechnology. 9. 727869–727869. 5 indexed citations
4.
Byiers, Breanne J., et al.. (2020). Associations Among Diurnal Salivary Cortisol Patterns, Medication Use, and Behavioral Phenotype Features in a Community Sample of Rett Syndrome. American Journal on Intellectual and Developmental Disabilities. 125(5). 353–368. 5 indexed citations
5.
Byiers, Breanne J., Chantel C. Barney, Kristin A. Frenn, et al.. (2019). Evidence of altered salivary cytokine concentrations in Rett syndrome and associations with clinical severity. Brain Behavior & Immunity - Health. 1. 100008–100008. 8 indexed citations
6.
Ehrhardt, Michael, Rogerio B. Craveiro, Julia Velz, et al.. (2018). The FDA approved PI3K inhibitor GDC‐0941 enhances in vitro the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma. Journal of Cellular and Molecular Medicine. 22(4). 2153–2161. 13 indexed citations
7.
Craveiro, Rogerio B., et al.. (2017). The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition. Oncotarget. 8(29). 46915–46927. 7 indexed citations
8.
Hui, Susanta, Yutaka Takahashi, Shernan G. Holtan, et al.. (2017). Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents. Radiotherapy and Oncology. 124(3). 468–474. 14 indexed citations
9.
Ehrhardt, Michael, et al.. (2016). A generic viral dynamic model to systematically characterize the interaction between oncolytic virus kinetics and tumor growth. European Journal of Pharmaceutical Sciences. 97. 38–46. 20 indexed citations
10.
11.
Raza, K., Andrew Price, Carolyn Meyer, et al.. (2014). MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant. PLoS ONE. 9(10). e109034–e109034. 14 indexed citations
12.
Ehrhardt, Michael, et al.. (2014). The PI3K inhibitor GDC-0941 displays promisingin vitro and in vivoefficacy for targeted medulloblastoma therapy. Oncotarget. 6(2). 802–813. 31 indexed citations
13.
Koks, Carolien, Abhishek D. Garg, Michael Ehrhardt, et al.. (2014). Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death. International Journal of Cancer. 136(5). E313–25. 175 indexed citations
14.
Ferguson, John, Imanol Arozarena, Michael Ehrhardt, & Claudia Wellbrock. (2012). Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene. 32(1). 86–96. 55 indexed citations
15.
Volkmann, D.H., et al.. (2009). Technical note: A rapid enzyme-linked immunosorbent assay blood test for pregnancy in dairy and beef cattle. Journal of Dairy Science. 92(8). 3819–3824. 38 indexed citations
16.
Taylor, Patricia A., Michael Ehrhardt, Christopher J. Lees, et al.. (2008). TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood. 112(8). 3508–3516. 70 indexed citations
17.
Taylor, Patricia A., Michael Ehrhardt, Christopher J. Lees, et al.. (2007). Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood. 110(9). 3480–3488. 63 indexed citations
18.
Taylor, Patricia A., Michael Ehrhardt, Matthew M. Roforth, et al.. (2006). Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 109(3). 1307–1315. 84 indexed citations
19.
Taylor, Patricia A., Christopher J. Lees, Jessica Wilson, et al.. (2002). Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood. 100(9). 3400–3407. 81 indexed citations
20.
Ehrhardt, Michael, et al.. (1979). [Application of the NSD-concept for the ascertainment of tolerance doses in the region of the lung (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 155(1). 10–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randall Armstrong Breakdown of academic impact, for papers by Amy Cuthbert Breakdown of academic impact, for papers by Sabine Hahn Breakdown of academic impact, for papers by William Siders Breakdown of academic impact, for papers by J. E. Landegent Breakdown of academic impact, for papers by Nancy Pech Breakdown of academic impact, for papers by Sohel Talib Breakdown of academic impact, for papers by Martina Minnich Breakdown of academic impact, for papers by Pierre Rollini
Rankless by CCL
2026